• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肌肉量与前列腺癌患者根治性前列腺切除术后生存的关系。

Association of Muscle Mass with Survival after Radical Prostatectomy in Patients with Prostate Cancer.

机构信息

Departments of Urology, Center for Urological Cancer, National Cancer Center, Goyang, Korea.

Department of Clinical Epidemiology and Biostatistics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.

出版信息

J Urol. 2019 Sep;202(3):525-532. doi: 10.1097/JU.0000000000000249. Epub 2019 Aug 8.

DOI:10.1097/JU.0000000000000249
PMID:30916628
Abstract

PURPOSE

Although muscle mass has been associated with survival in patients with various types of solid tumors, the relationship between muscle mass and survival in patients with prostate cancer remains unclear. We retrospectively investigated the association of muscle mass with survival after radical prostatectomy in patients with prostate cancer.

MATERIALS AND METHODS

We reviewed the records of 2,042 patients who underwent radical prostatectomy of prostate cancer between 1998 and 2013. Muscle mass was evaluated by measuring the psoas muscle index on preoperative computerized tomography images.

RESULTS

In the lowest, second, third and highest psoas muscle index quartiles the 10-year distant metastasis-free survival rate was 72.5%, 83.8%, 92.3% and 93.7% (p <0.001), the 10-year cancer specific survival rate was 85.7%, 92.1%, 96.8% and 97.6%, and the 10-year overall survival rate was 74.5%, 79.6%, 89.8% and 90.6%, respectively (each p <0.001). The psoas muscle index positively correlated with the body mass index, serum concentrations of IGFBP-3 and bioavailable testosterone, and inversely correlated with patient age, the serum SHBG concentration and the neutrophil-to-lymphocyte ratio. On multivariable analysis the psoas muscle index was independently associated with increased risks of biochemical recurrence, distant metastasis, and cancer specific and overall death.

CONCLUSIONS

Low muscle mass may be associated with increased risks of recurrence and mortality in patients who undergo radical prostatectomy of prostate cancer regardless of the body mass index. Large-scale prospective studies are warranted.

摘要

目的

尽管肌肉质量与各种类型实体瘤患者的生存相关,但肌肉质量与前列腺癌患者生存的关系尚不清楚。我们回顾性调查了肌肉质量与前列腺癌根治性前列腺切除术后生存的关系。

材料和方法

我们回顾了 1998 年至 2013 年间接受根治性前列腺切除术的 2042 例前列腺癌患者的记录。通过术前计算机断层扫描图像测量腰大肌指数来评估肌肉质量。

结果

在最低、第二、第三和最高腰大肌指数四分位数中,10 年远处无转移生存率分别为 72.5%、83.8%、92.3%和 93.7%(p<0.001),10 年癌症特异性生存率分别为 85.7%、92.1%、96.8%和 97.6%,10 年总生存率分别为 74.5%、79.6%、89.8%和 90.6%(p<0.001)。腰大肌指数与体重指数、血清 IGFBP-3 和生物可利用睾酮浓度呈正相关,与患者年龄、血清 SHBG 浓度和中性粒细胞与淋巴细胞比值呈负相关。多变量分析显示,腰大肌指数与生化复发、远处转移以及癌症特异性和总死亡的风险增加独立相关。

结论

无论体重指数如何,肌肉质量低可能与前列腺癌根治性前列腺切除术后患者的复发和死亡风险增加相关。需要进行大规模前瞻性研究。

相似文献

1
Association of Muscle Mass with Survival after Radical Prostatectomy in Patients with Prostate Cancer.肌肉量与前列腺癌患者根治性前列腺切除术后生存的关系。
J Urol. 2019 Sep;202(3):525-532. doi: 10.1097/JU.0000000000000249. Epub 2019 Aug 8.
2
Obesity and long-term survival after radical prostatectomy.肥胖与根治性前列腺切除术的长期生存
J Urol. 2014 Oct;192(4):1100-4. doi: 10.1016/j.juro.2014.04.086. Epub 2014 Apr 21.
3
Predictors of biochemical recurrence after Retzius-sparing robot-assisted radical prostatectomy: Analysis of 359 cases with a median follow-up period of 26 months.保留Retzius间隙的机器人辅助根治性前列腺切除术后生化复发的预测因素:359例患者分析,中位随访期26个月
Int J Urol. 2018 Dec;25(12):1006-1014. doi: 10.1111/iju.13808. Epub 2018 Oct 1.
4
Stage T1-2 prostate cancer: a multivariate analysis of factors affecting biochemical and clinical failures after radical prostatectomy.T1-2期前列腺癌:根治性前列腺切除术后影响生化及临床失败因素的多变量分析
Int J Radiat Oncol Biol Phys. 1997 Mar 15;37(5):1043-52. doi: 10.1016/s0360-3016(96)00590-1.
5
Predictive factors of biochemical recurrence after radical prostatectomy for high-risk prostate cancer.高危前列腺癌根治性前列腺切除术后生化复发的预测因素。
Int J Urol. 2018 Mar;25(3):284-289. doi: 10.1111/iju.13514. Epub 2018 Jan 8.
6
Oncologic and Functional Outcomes after Radical Prostatectomy for High or Very High Risk Prostate Cancer: European Validation of the Current NCCN® Guideline.根治性前列腺切除术治疗高危或极高危前列腺癌的肿瘤学和功能学结局:当前 NCCN®指南的欧洲验证。
J Urol. 2017 Aug;198(2):354-361. doi: 10.1016/j.juro.2017.02.070. Epub 2017 Feb 16.
7
The ratio of oleic-to-stearic acid in the prostate predicts biochemical failure after radical prostatectomy for localized prostate cancer.前列腺中油酸与硬脂酸的比例可预测局限性前列腺癌根治性前列腺切除术后的生化复发。
J Urol. 2007 Dec;178(6):2391-6; discussion 2396. doi: 10.1016/j.juro.2007.08.005. Epub 2007 Oct 22.
8
Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer.临床局限性前列腺癌根治性前列腺切除术后的生化(前列腺特异性抗原)复发概率。
J Urol. 2003 Feb;169(2):517-23. doi: 10.1097/01.ju.0000045749.90353.c7.
9
Oncologic outcomes at 10 years following robotic radical prostatectomy.机器人辅助根治性前列腺切除术 10 年后的肿瘤学结果。
Eur Urol. 2015 Jun;67(6):1168-1176. doi: 10.1016/j.eururo.2014.06.025. Epub 2014 Jul 2.
10
Time to prostate specific antigen recurrence after radical prostatectomy and risk of prostate cancer specific mortality.根治性前列腺切除术后前列腺特异性抗原复发时间与前列腺癌特异性死亡风险
J Urol. 2006 Oct;176(4 Pt 1):1404-8. doi: 10.1016/j.juro.2006.06.017.

引用本文的文献

1
Advances in sarcopenia and urologic disorders.肌肉减少症与泌尿系统疾病的研究进展。
Front Nutr. 2024 Nov 6;11:1475977. doi: 10.3389/fnut.2024.1475977. eCollection 2024.
2
Psoas mass index at the level of the third lumbar vertebra on computed tomography is a prognostic predictor for metastatic castration-sensitive prostate cancer.CT 扫描第 3 腰椎水平的腰大肌质量指数是转移性去势敏感性前列腺癌的预后预测指标。
Int J Clin Oncol. 2024 Jun;29(6):840-846. doi: 10.1007/s10147-024-02514-2. Epub 2024 Apr 8.
3
Associations of Total Body Fat Mass and Skeletal Muscle Index with All-Cause and Cancer-Specific Mortality in Cancer Survivors.
癌症幸存者全身脂肪量和骨骼肌指数与全因死亡率及癌症特异性死亡率的关联。
Cancers (Basel). 2023 Feb 8;15(4):1081. doi: 10.3390/cancers15041081.
4
Does Androgen Deprivation for Prostate Cancer Affect Normal Adaptation to Resistance Exercise?雄激素剥夺治疗前列腺癌是否会影响正常适应抗阻运动?
Int J Environ Res Public Health. 2022 Mar 23;19(7):3820. doi: 10.3390/ijerph19073820.
5
Prognostic Impact of Sarcopenia in Patients with Metastatic Hormone-Sensitive Prostate Cancer.肌肉减少症对转移性激素敏感性前列腺癌患者的预后影响
Cancers (Basel). 2021 Dec 17;13(24):6345. doi: 10.3390/cancers13246345.
6
Associations of fat and muscle mass with overall survival in men with prostate cancer: a systematic review with meta-analysis.脂肪和肌肉质量与前列腺癌男性患者总生存的相关性:系统评价与荟萃分析。
Prostate Cancer Prostatic Dis. 2022 Apr;25(4):615-626. doi: 10.1038/s41391-021-00442-0. Epub 2021 Aug 21.
7
Body Composition Analysis of 10 Years versus 5 Years of Adjuvant Endocrine Therapy in Patients with Nonmetastatic Breast Cancer.非转移性乳腺癌患者辅助内分泌治疗10年与5年的身体成分分析
J Oncol. 2021 Jan 16;2021:6659680. doi: 10.1155/2021/6659680. eCollection 2021.
8
CT-based assessment of body composition following neoadjuvant chemohormonal therapy in patients with castration-naïve oligometastatic prostate cancer.基于CT对初治寡转移前列腺癌患者新辅助化疗联合激素治疗后身体成分的评估
Prostate. 2021 Feb;81(2):127-134. doi: 10.1002/pros.24088. Epub 2020 Dec 1.
9
Muscle Characteristics Obtained Using Computed Tomography as Prognosticators in Patients with Castration-Resistant Prostate Cancer.利用计算机断层扫描获得的肌肉特征作为去势抵抗性前列腺癌患者的预后指标
Cancers (Basel). 2020 Jul 10;12(7):1864. doi: 10.3390/cancers12071864.
10
Pathophysiological mechanisms explaining poor clinical outcome of older cancer patients with low skeletal muscle mass.解释低骨骼肌量老年癌症患者临床结局差的病理生理机制。
Acta Physiol (Oxf). 2021 Jan;231(1):e13516. doi: 10.1111/apha.13516. Epub 2020 Jul 24.